Category: ACN Newswire

HONG KONG, Mar 31, 2026 - (ACN Newswire via SeaPRwire.com) - On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group’s total revenue reached RMB173.43 billion, and adjusted industrial operation profit was RMB4 billion.Compared to prior years, Fosun’s results have remained solid. However, pursuant to the principle of prudence, Fosun made one-off non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of RMB23.4 billion in 2025, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%.Fosun emphasized in the announcement that these provisions do not affect the Company’s overall operations and cash flow. However, Guo Guangchang, Chairman of Fosun International, offered a sincere apology in this year’s Letter to Shareholders, stating that “A loss is never desirable.” He further explained that, “Under the current market conditions, some of the projects we invested in years ago are now valued differently from what we expected at the time of investment. Accordingly, the Board has taken a prudent decision to complete this asset impairment, allowing Fosun to focus its resources and efforts more effectively on core, high-growth areas. At a time when the global economy is generating opportunities amid volatility and China’s innovation-driven industries are gaining growth momentum, deepening our strategic focus now allows us to optimize our asset structure and helps us secure a stronger position in key sectors, positioning Fosun as a leaner, healthier, and more sustainable company.”In recent years, Fosun has steadily advance its strategy of “streamlining operations and strengthening the business, focusing on core businesses”, generating approximately RMB75 billion in cash returns from asset and business divestments. This round of impairments marks Fosun’s decisive step to clear accumulated risks on a one-off basis and shed “historical burdens”. While the book loss appears significant, from the capital market’s perspective, Fosun’s share price has rebounded more than 10% since the announcement of its results preview on 6 March, indicating the market has recognized and accepted its “risk clearance”.In his Letter to Shareholders, Guo Guangchang described this asset impairment as “repairing the roof on a sunny day”. Fosun International’s results announcement offers a clear illustration. Fosun’s core businesses has continued to deliver steady profits, reflecting solid operating fundamentals. At the same time, its long-established innovation and globalization strategies have become the core growth drivers for the Company. Collectively, these achievements underpin Fosun’s confidence in proceeding with “risk clearance” at this stage.Business fundamentals remain solid, pharmaceuticals and insurance segments deliver strong resultsLet’s start with Fosun’s business fundamentals. In 2025, Fosun International’s four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group’s total revenue. This demonstrates the results of Fosun’s strategic adjustment of “focusing on core businesses”, effectively addressing prior market concerns over “diversification”.Among them, Fosun Pharma, a core subsidiary of Fosun, achieved a net profit attributable to shareholders of the parent of RMB3.371 billion in 2025, representing a year-on-year increase of 21.69%. Fosun Pharma’s biopharmaceutical innovation platform, Henlius, recorded revenue of RMB6.667 billion and net profit of RMB827 million, delivering growth in both revenue and net profit for the third consecutive year.Next, let’s take a look at Fosun’s most important overseas subsidiary, Fosun Insurance Portugal. In 2025, Fosun Insurance Portugal achieved strong growth in revenue and net profit. Its net profit attributable to owners of the parent amounted to EUR201 million, up 15.8% year-on-year, establishing it as a stable contributor to Fosun’s profitability. Fosun Insurance Portugal has benefited significantly from Fosun’s global ecosystem, expanding its presence from Portugal to overseas markets such as Europe, Latin America and Africa. In 2025, Fosun Insurance Portugal received its inaugural A rating from S&P Global, reflecting international recognition of its asset quality and risk resilience.In Chinese mainland, Fosun’s two insurance companies have also performed well. Pramerica Fosun Life Insurance’s premium income for the year reached RMB13.28 billion, up 41.6% year-on-year, while net profit surged over 492% to RMB650 million. Meanwhile, Fosun United Health Insurance recorded insurance income of RMB7.84 billion in 2025, representing a year-on-year increase of 50.1%, with net profit reaching RMB139 million, marking five consecutive years of profitability.Core drivers: innovation and globalization strategiesFosun Pharma and Fosun Insurance Portugal embody Fosun’s two core strategies: innovation and globalization.Since its establishment, Fosun has always regarded “innovation-driven research and development (R&D)” as its core strategy, and began its global expansion following its listing in Hong Kong. After years of intensive investment and exploration, innovation and globalization strategies have become the core driving forces behind Fosun’s development, consistently delivering results that generate “compounding returns” over time.The biggest change for Fosun Pharma in 2025 was strong growth in its innovative drug breakthroughs. During the Reporting Period, Fosun Pharma’s revenue from innovative drugs reached RMB9.893 billion, representing a year-on-year increase of 29.59%, accounting for 33.16% of its pharmaceutical business revenue. Fosun Pharma had 16 indications of its 7 innovative drugs approved for marketing in China and overseas markets, while marketing applications for 6 innovative drug candidates were accepted.During the Reporting Period, nearly 40 of Fosun’s innovative drug clinical trials were approved by regulatory authorities in China, the United States and Europe, while multiple core products entered key clinical phases, laying a solid pipeline foundation for subsequent commercial growth.Henlius’ HLX43 remains the main focus of market interest. As a PD-L1-targeted antibody drug conjugate (ADC) with potential best-in-class characteristics and broad anti-tumor activity across multiple tumor types, HLX43 has shown significant advantages, with a favorable efficacy and safety profile in non-small cell lung cancer (NSCLC), gynecological tumors, esophageal squamous cell carcinoma (ESCC), and other indications. On 27 January 2025, it was approved for clinical trials in Chinese mainland, positioning it to become another landmark product for Fosun.This year, Fosun’s international business development (BD) efforts for innovative drugs made a notable impression on the market. For example, at the beginning of 2026, Fosun Pharma entered into an agreement with Eisai Co., Ltd. in relation to HANSIZHUANG, with a potential total value of over USD300 million. At the end of 2025, Fosun Pharma’s subsidiary, Yao Pharma, signed a global exclusive licensing agreement with Pfizer, with a potential total value of over USD2 billion; Fosun Pharma Industrial entered into a strategic collaboration with biotechnology company Clavis Bio, with Fosun Pharma eligible to receive up to USD7.25 billion in payments.In terms of globalization, Fosun has established a profound business presence in more than 40 countries and regions worldwide. Today, it has achieved comprehensive globalization across products, services, and brands. In 2025, Fosun’s overseas revenue reached RMB94.86 billion, accounting for 54.7% of total revenue, representing a year-on-year increase of 5.4 percentage points. Fosun’s globalization strategy has evolved from “acquiring globally” to “earning globally”.Club Med, a subsidiary of Fosun Tourism Group, operates 67 resorts worldwide. During the Reporting Period, Club Med once again achieved record-high performance, with revenue reaching RMB18.07 billion, representing a year-on-year increase of 3.6%, while operating profit reached RMB1.44 billion, up 4.6% from 2024.Hainan Mining, a subsidiary of Fosun, has now developed into a global resource + new energy company and has made remarkable strides in its global expansion. Hainan Mining’s model of “overseas resources + processing in Hainan” entered a substantive operational stage in 2025. Its Bougouni Lithium Mine in Mali produced 45,000 tons of lithium concentrate, with the first shipment of 30,000 tons arriving at Yangpu Port in Hainan in January 2026. Additionally, through its subsidiary Roc Oil and the newly acquired oilfield project in Oman, Hainan Mining has accelerated the building of a “minerals + energy” network spanning West Africa, the Middle East, and Southeast Asia.International rating agencies affirm Fosun International’s rating outlook as “stable”Fosun’s financial position remains the market’s primary focus.According to Fosun International’s results announcement, during the Reporting Period, cash, bank balances and term deposits amounted to RMB61.1 billion; unutilized banking facilities amounted to RMB144.6 billion; total debt to total capital ratio was 57%. Fosun has maintained a healthy financial position, with ample cash reserves. International rating agencies have broadly affirmed Fosun International’s rating outlook as “stable”.Guo Guangchang stated in his Letter to Shareholders that, at present, Fosun’s core businesses remain solid, liquidity position is robust, and banking relationships remain stable. The Company’s major shareholder and management team have announced plans to increase their holdings in the shares of the Company and the Company will also proceed with a share buyback program. With Fosun’s core businesses continuing to grow and strategic plans firmly on track, “We are confident in our ability to support a return of the share price to fair value and better protect the long-term interests of our shareholders.”In addition to its results announcement, Fosun announced that it is committed to increasing its dividend payout ratio, targeting an increase from the current 20% to 35% for the 2026 financial year. Based on the accumulated distributable profit of the Company, the dividend for the 2026 financial year is expected to be not less than HKD1.5 billion.We can reasonably expect that this round of “strategic streamlining” will inject greater certainty into Fosun’s future business growth.In this year’s Letter to Shareholders, Guo Guangchang also disclosed Fosun’s medium-term financial goals: “We strive to gradually restore annual profit to the RMB10 billion level; at the group level, we aim to generate RMB60 billion in cash returns, reduce total debt to below RMB60 billion, and strive to achieve an investment-grade rating.” He stated that, “Fosun has always stayed true to its original aspiration: to do the right things, the difficult things and the things that take time to develop. For Fosun’s future, we do not seek short-term gains; we seek to build a foundation for lasting success.” Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月31日 - (亞太商訊 via SeaPRwire.com) - 2026年3月31日，聯想控股股份有限公司（「聯想控股」或「公司」；股份代號：3396.HK）於今日公佈截至2025年12月31日止年度（「報告期」）之經審核全年業績，公司收入6059.45億元（人民幣，下同），同比增長18%；淨利潤97.99億元，同比增長28%；歸屬於本公司權益持有人淨利潤10.61億元，同比實現大幅增長。利潤增長主要受益於資本市場回暖，產業孵化與投資板塊業務虧損同比減少所致。此外，公司董事會建議派付末期股息每股0.1元（除稅前）。2025年，中國經濟繼續展現出強大韌性，作為「十四五」收官之年，向新向優發展突出，聯想控股始終堅持產業報國初心，緊扣國家戰略導向，向科技創新深水區邁進，聚焦實體經濟，與社會各界共同培育和發展新質生產力。構建特色科創體系 驅動高質量發展聯想控股積極響應國家創新驅動發展戰略，持續加大在研發領域的投入力度，2025年研發費用超170億元，同比增長10%，創下歷史新高；在「十四五」期間，研發費用總規模超750億元，較「十三五」期間增長超60%。在研發上的堅定投入也帶來顯著回報，推出的全球首款AI PC引領行業變革，目前PC全球市佔率超過25%，牢牢佔據行業第一；AI服務器和海神液冷系統獲得全球市場高度認可，位列服務器全球前三；智能服務業務登頂中國IT服務榜首，並推出一系列生成式AI解決方案，引領行業從IT服務走向AI服務。同時期，聯想控股積極參與中國科技生態建設，加大了對中國前沿科技的投資，圍繞國家新興支柱產業和未來產業，在包括AI、具身智能、商業航天、低空經濟、新能源新材料、可控核聚變、芯片半導體、量子計算、生物醫藥等前沿領域，保持平均每年新投和追投超100家中國科技企業的節奏。尤其在AI領域，聯控體系投資超300家企業，是中國在AI領域投資時間最長，覆蓋最全面的機構。2025年，公司投資了近150家中國科技企業，推動了15家被投企業登陸資本市場，名列市場前茅。響應國家「科技創新與產業創新深度融合」號召，聯想控股積極踐行企業科技創新主體地位，公司前瞻技術研究院加大在早期前沿技術成果產業化方向的探索，已與60餘家企業及科研機構建立聯繫，與兩所高校及7家國內外企業啟動深度合作，並篩選了39項種子技術。今年初，公司與北京大學光子傳輸與通信全國重點實驗室合作成立的「北京大學-聯想控股先進光子集成技術聯合實驗室」正是代表案例之一。此外，聯控體系在前沿技術和核心技術自主化方面取得多項成果。聯想集團下屬聯想研究院聚焦AI領域，推出了天禧、聯想Qira等全球領先的L3級超級智能體，研發了X-Engine端側推理引擎，大幅提升了AI PC體驗。聯泓新科下屬聯泓研究院聚焦新材料，在固態與半固態電池材料、PEEK材料等領域打破技術壟斷，和中國科學院合作的兩個課題被列入國家科技部的國家重點研發計劃。聚力實體經濟 夯實產業根基「十四五」期間，聯想控股扎根實體經濟，以先進製造業為骨幹，新增投資超200億元，預計實現產值超千億元。其中，聯想集團在深圳建成其全球智能製造的母本工廠——深圳南方基地，獲評國家《智能製造能力成熟度模型》最高等級認證；其天津工廠也被評為全球最高等級的「生態級零碳工廠」。聯想集團通過在中國構建起四座大型工廠，確保了中國IT相關產業鏈、供應鏈的穩定安全，並帶動地方經濟發展。聯泓新科在山東新建了聯泓格潤新能源材料和生物可降解材料一體化項目，年產20萬噸/年EVA、30萬噸/年PO，在江蘇新建10萬噸/年POE項目，並先後在多地建設了可降解材料PLA、超高分子量聚乙烯等項目，填補中國在相關領域的空白。深化ESG實踐 厚植多元價值聯想控股堅定踐行綠色發展道路，追求經濟、社會、環境價值的和諧統一與共同提升。聯想集團蟬聯4屆MSCI ESG 最高AAA評級，承諾到2050年底實現整體價值鏈溫室氣體淨零排放，是中國首家通過SBTi驗證的高科技製造企業。聯泓新科圍繞綠色產業打造綠色產品矩陣，鞏固了光伏膠膜料產業龍頭地位，陸續進入生物可降解材料、新能源電池材料等領域，榮膺國家級綠色工廠。此外，聯控在科技創新及鄉村振興等領域積極履行企業社會責任，其中，聯想之星創業CEO特訓班免費為國內科技創業者提供創業培訓，設立以來，聯控保持每年上千萬投入，截至2025年底，累計投入1.6億元，共培養1,429名創新創業企業家人才，現有71家「星友」創辦企業實現上市，216家入選國家級專精特新「小巨人」企業，帶動社會就業近46萬人。積澱戰略定力 智變錨定未來以高質量發展為主線，聯想控股強化自主創新，穩步推進資產組合優化，加強資源回收。五年來，公司合計回流資金超450億元，有力支撐了對科技創新和實體經濟的大規模投入。展望「十五五」時期，聯想控股將更加主動地融入到高質量發展的時代大潮中，強化科技創新引領，聚焦實體經濟，以長期主義戰略定力扎實推進新質生產力發展，堅定落實重大科技成果轉化，支持高水平科技自立自強。公司將持續加大在AI、新材料等國家新興支柱產業的科研投入；繼續保持對中國科創生態及創新創業企業的體系化支持；加大資產組合調整，構建起符合時代特徵的產業佈局；推動多元業務協同創新，打造差異化創新生態；在全球前沿技術商業化領域建立起具有聯想特色的可複製商業模式，並持續產出成果。此外，聯控將進一步夯實產業基礎，強化核心競爭力，積極履行社會責任，推動美麗中國建設。聯想控股董事長、執行董事寧旻先生表示，過去一年，聯想控股交出了一份韌性彰顯，質量提升的答卷，背後是科技創新戰略的清晰指引，更離不開國家推動新質生產力、建設現代化產業體系所帶來的廣闊市場空間。我們將牢牢把握住「十五五」時期的戰略機遇，以更加堅定的創新步伐、更加開放的產業生態、更加務實的社會貢獻，讓企業與國家發展同頻共振，為股東、為社會創造出更大的價值，做好中國式現代化的堅定踐行者。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月31日 - (亞太商訊 via SeaPRwire.com) - 山東極視角科技股份有限公司（以下簡稱「極視角」）即將於3月30日登陸香港聯合交易所主板，衝擊「視覺語言大模型第一股」。這家成立於2015年的AI視覺公司，用十年時間從深圳起步，紮根山東青島，成長為國家級專精特新「小巨人」與福布斯中國「獨角獸」。截至2025年9月30日，公司累計交付項目超過6,000個，產品復購率超過80%，客戶覆蓋逾100個行業，並於2024年成功實現盈利，成為國內少數實現盈利的AI視覺企業之一。在這份成績單背後，是一條與眾不同的商業化路徑。而這條路徑的起點，要從三位「90後」創始人的創業初心說起。三位「90後」的產業初心：讓AI不再「懸浮」極視角的創始人陳振傑，1992年出生於澳門，在北大求學期間便對商業與技術的結合產生濃厚興趣。憑藉敏銳的商業洞察力，加之聯合創始人羅韻在香港科技大学攻读人工智能博士的學術研究領域的專長，2015年，他們共同創立極視角，立志將AI技術轉化為真正改變產業的生產力。十年間，陳振傑帶領團隊從深圳起步，將總部遷至產業基礎雄厚的山東青島，一步一個腳印深耕B端市場。他本人先後入選《福布斯》「亞洲30位30歲以下精英榜」和胡潤U30中國創業領袖榜，並成為國家科技創業領軍人才。極視角的現任執行董事兼副總經理陳碩曾公開表示：「我們讀碩士和博士期間，就預感到人工智能將會應用於千行百業，場景也會呈現多樣化與碎片化，只靠一家企業無法滿足所有需求。於是我們開創了『算法商城』模式。」正是這一模式，奠定了極視角與眾不同的商業化路徑。破解「碎片化」難題：構建獨特「自研+生態」模式正是早期對產業一線的深入觀察，讓陳振傑敏銳地捕捉到B端市場的核心痛點。他曾提到，「B端市場最大的痛點正是『碎片化』。」不同行業、不同企業、甚至同一企業的不同生產環節，對AI的需求千差萬別。如果每個場景都需要從零開始開發算法，成本高昂，周期漫長，根本無法規模化。面對碎片化的市場需求，極視角的應對策略是將AI解決方案的開發過程「拆解」和「重構」。公司自主研發了AI視覺語言模型作為底層能力，同時打造算法開發平台「極市」和交付平台「極星」「極棧」，通過平台化、工具化的方式，大幅降低算法開發的成本和門檻。具體而言，極市專注於計算機視覺算法，為開發者提供全面的基礎設施支持，包括在線編程工具、大模型API、訓練任務管理、自動測試及多種芯片的硬件兼容性，可显著提升算法开发效率。通過利用真實世界場景數據，極市平台训练的算法也可实现高识别准确率。基於這套自主研發的全棧式技術平台，極視角構建起獨特的「自研+生態」模式。截至2025年9月30日，公司的AI計算機視覺算法商城已展示逾1,500種算法，涵蓋逾100個行業。更重要的是，公司建立了由數十萬AI算法開發者組成的全球社區，累計服務客戶超過3,000名，自成立以來已交付逾6,000個項目。算法保持90%以上的準確率，並可靈活組合、定製，滿足不同客戶的個性化需求。此外，在自主研發的全棧式工具鏈及可擴展的開發者生態系統的支持下，公司將項目交付週期縮短至僅需八至十週，遠快於行業平均水平。盈利能力強勁：收入、利潤、毛利率持續向好商業模式的可行性，最終體現在財務數據上。公司收入由2022年的1.016億元增長至2024年的2.573億元，複合年增長率達59.2%；毛利率由2022年的30.6%提升至2024年的40.2%；2024年錄得年內利潤871萬元。截至2025年9月30日止九個月，公司實現收入1.363億元，同比增長71.7%，毛利率進一步提升至44.9%。憑藉先進的技術積澱與全棧式AI基礎設施，極視角已在計算機視覺解決方案及大模型解決方案領域確立穩固地位。根據弗若斯特沙利文的數據，按銷售收入計，公司2024年在中國新興企業級計算機視覺解決方案市場以軟件為中心的提供商中排名第三，占有1.6%的市場份額。公司還憑藉技術實力入選工信部人工智能揭榜掛帥任務，進一步驗證了其在行業中的創新能力。展望未來，AI技術在B端市場的滲透空間仍然廣闊。根據弗若斯特沙利文的數據，中國企業級計算機視覺解決方案市場規模預計將從2024年的111億元增長至2029年的970億元，年複合增長率高達54.3%。公司表示，未來將持續加大研發投入，不斷迭代AI視覺語言模型及核心平台能力，在開發、訓練與部署AI計算機視覺及大模型解決方案方面，保持行業領先地位。從三位「90後」的創業初心，到千行百業的AI落地，極視角正以穩健的耐力與清晰的路徑，在AI商業化的長跑中行穩致遠。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 31, 2026 - (ACN Newswire via SeaPRwire.com) - Bringing artificial intelligence from the laboratory to a broad spectrum of industries—particularly in the B2B market—demands that AI companies overcome a formidable set of challenges: how to precisely match complex, ever-evolving business scenarios; how to achieve scalable delivery; and how to establish a sustainable business model.Extreme Vision, based in Qingdao, Shandong, has delivered its answer through a compelling set of metrics. As of September 30, 2025, the Company had completed over 6,000 projects, recorded a product repurchase rate exceeding 80%, and served more than 100 industries, including manufacturing, energy, retail, and transportation. Revenue grew from RMB101.6 million in 2022 to RMB257.3 million in 2024, representing a compound annual growth rate of 59.2%. The Company turned profitable in 2024.A Platform-based Approach to Tackling the Fragmentation ChallengeExtreme Vision was founded by three entrepreneurs born in the 1990s: Mr. Chan Chan Kit, Ms. Luo Yun, and Mr. Chen Shuo. Mr. Chan Chan Kit holds a direct stake of 16.05% in the Company and serves as its largest shareholder, legal representative, chairman of the board, executive director, and general manager. The three founders, all alumni of Sun Yat-sen University, first conceived the idea of starting a business during their undergraduate studies.“The biggest challenge in the B2B market is fragmentation,” Mr. Chan once noted. Different industries, different enterprises, and even different production processes within the same company all have vastly different AI requirements. If each scenario requires developing algorithms from scratch, the cost is prohibitive, the timeline is protracted, and scaling becomes virtually impossible. This is precisely the “B2B chasm” that many AI companies struggle to cross. Based on this insight, Extreme Vision pioneered the AI Vision Algorithm Marketplace.As of September 30, 2025, Extreme Vision’s algorithm marketplace has launched 1,517 algorithms, including 1,369 algorithms co-developed with third-party developers. Covering application scenarios in over 100 industries, the platform has served more than 3,000 customers and delivered over 6,000 projects since its establishment. Notably, the product repurchase rate has exceeded 80%, reflecting the strong standardization of its solutions and robust market recognition.Self-developed AI infrastructure empowers efficient implementation. The Company’s self-developed AI infrastructure enables efficient algorithm development and rapid solution development. On the one hand, leveraging its self-developed full-stack technology platform, Extreme Vision has built an industry-leading AI infrastructure that covers the entire lifecycle, including data annotation, model training, algorithm development, algorithm testing and inference deployment. On the other hand, the integrated tool engines within its AI development infrastructure significantly lowering the barriers to algorithm development and drastically reducing the time required for customized algorithm development.Multi-industry Implementation: Project Practice as a Driver for Healthy GrowthLeveraging its platform-based capabilities, Extreme Vision has applied its technology to real-world business scenarios across various sectors, delivering actionable and reusable solutions.In terms of industrial manufacturing, Extreme Vision deployed an EHS+AI intelligent monitoring system for CR Beer. By implementing 25 categories of risk-identification algorithms, the system accurately captures risk scenarios such as the improper wearing of safety ropes and goggles, hoisting operations, and unauthorized personnel intrusion during equipment operation. This has successfully transformed traditional passive safety management into proactive, real-time, and automated risk control.In terms of environmental and energy sectors, Extreme Vision has built an intelligent security management platform, “Halo Guard” for China Everbright Environmental Energy. Equipped with nearly 30 AI vision algorithms for safety management and control, the platform conducts real-time monitoring of high-risk operational scenarios such as unloading platforms and burning zones, significantly enhancing operational safety.In the higher education sector, Extreme Vision has jointly established the “Artificial Intelligence Comprehensive Practice Center” with the School of Smart City at Beijing Union University. Leveraging its Extreme Flow platform, the Company supports algorithm teaching and research in universities, helping to cultivate AI talent.In the transportation and mobility sector, Extreme Vision has identified new application scenarios for large model solutions. Using large model technologies, the Company has generated autonomous driving simulation scenario data and conducted hallucination detection for a leading automotive retailer, helping the client reduce reliance on real-world road data collection and optimize the R&D process.These projects not only demonstrate the breadth and depth of Extreme Vision's technology implementation but also collectively underpin the Company's sustained growth. Each successfully delivered project generates experience and reusable modules for future projects, creating a virtuous cycle that contributes to a product repurchase rate of over 80%.Profitability Continuously Validated, Large Model Emerges as a New Growth DriverAs its commercial value continues to be validated, Extreme Vision's profitability has also shown strong growth momentum. The Company's revenue grew from RMB101.6 million in 2022 to RMB257.3 million in 2024, representing a compound annual growth rate (CAGR) of 59.2%. The gross profit margin improved from 30.6% in 2022 to 40.2% in 2024. The Company recorded a profit of RMB8.71 million in 2024, making it one of the few profitable AI vision companies in China. For the nine months ended September 30, 2025, the Company achieved revenue of RMB136.3 million, a year-on-year increase of 71.7%, with the gross profit margin further rising to 44.9%.Notably, the large model solutions launched by the Company in 2024 contributed RMB62.12 million in revenue, accounting for 24.1% of total revenue. This has become a new growth driver and is expected to unlock further market opportunities.In terms of R&D investment, the Company continued to increase its efforts. R&D expenditure reached RMB44.82 million in 2024, an increase of 22.6% compared to 2023. As of September 30, 2025, the Company had a professional team of 101 R&D personnel. According to the Prospectus, the Company intends to use approximately 60.0% of the net proceeds from the IPO (HK$260.6 million) to enhance R&D capabilities, including the construction of large models and AI infrastructure, as well as the upgrade of AI-PaaS middleware.Broad Market Prospects: The Platform Flywheel AcceleratesIndustry prospects are promising. According to Frost & Sullivan, the market size of China’s emerging enterprise-level computer vision solutions is projected to grow from RMB11.1 billion in 2024 to RMB97.0 billion in 2029, representing a CAGR of 54.3%. This represents an almost eightfold increase in market size over the next five years, indicating strong inherent growth potential in the sector.As large models gain traction globally, market expectations for AI have been further elevated. However, in the B2B market, no matter how cutting-edge the technology is, it must ultimately return to the simple logic of “usability, practicality, and cost controllability.” Extreme Vision's experience shows that a competitive edge for AI companies lies not only in technological leadership but also in the ability to develop standardized solutions for complex industrial scenarios and scale them through platforms and ecosystems.From algorithms to applications, from project delivery to customer retention, Extreme Vision has remained committed to its mission of pushing technological boundaries and harnessing technology for good—building an AI flywheel that continuously generates commercial value. As AI technology permeates all industries, from industrial safety and energy inspection to retail operations, the demand for fragmented long-tail scenarios continues to emerge, positioning Extreme Vision for accelerated growth. However, whether it can continuously increase market share and improve cash flow amid fierce competition remains a core challenge post-listing. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月31日 - (亞太商訊 via SeaPRwire.com) - 3月30日晚，復星國際公佈2025年度業績。報告期內，集團總收入達人民幣1,734.3億元，經調整產業運營利潤為人民幣40億元。和往年業績相比較，復星業績數據保持穩健。不過這一年復星依據審慎性原則對部分存在減值跡象的地產項目及部分非核心業務板塊的商譽、無形資產進行了一次性非現金減值計提和價值重估，造成年度賬面虧損人民幣234億元，其中地產減值佔比約55%，非核心資產減值佔比約45%。公告特別強調，這次計提對公司整體運營和現金流沒有影響。不過作為復星的當家人，復星國際董事長郭廣昌在今年《致股東信》中坦誠道歉：「虧損總是不好的。」他也進一步解釋，「復星過往佈局的一些項目，確實在當前的市場形勢和投資之初存在價值的偏差，因此，董事會審慎選擇完成這次計提，核心目的之一就是消除不確定性。經過這次計提，復星可以更好地集中資源、集中精力，投向高增長核心賽道。當前全球經濟在波動中醖釀機遇、中國創新產業迎來發展趨勢，此時深化佈局，既能優化資產結構，更能佔穩行業先機，讓復星更輕盈、健康、可持續。」近幾年來，復星持續推進「瘦身健體、聚焦主業」戰略，已退出資產和業務回籠資金約人民幣750億元。這次通過計提，對長期業務積累的風險一次性出清，放下「包袱」，是復星走出的果敢一步。賬面虧損數字雖然較大，但從資本市場來看，復星自3月6日發佈業績預告以來，股價已反彈超過10%，顯示復星的「風險出清」，已被市場認可和消化。郭廣昌在《致股東信》中表示，這一次減值是「晴天修屋頂」。透視復星國際的業績公告，可以發現此言不虛。復星旗下核心主業持續貢獻穩定利潤，運營基本面穩健；同時多年推進的創新和全球化戰略，已成為企業發展的核心引擎。綜合來看，這正是復星在此時推進「風險出清」的底氣所在。業務基本盤穩健，醫藥、保險業務表現亮眼先說業務基本盤。2025年，復星國際四大核心子公司收入人民幣1,282億元，已佔到集團總收入的74%。這顯示了復星「聚焦主業」戰略調整的成果，過去市場對復星業務「多元化」的議論，此時可以休矣。其中，核心子公司復星醫藥，2025年歸母淨利潤人民幣33.71億元，同比增長21.69%。復星醫藥旗下的生物醫藥創新平台復宏漢霖，2025年也實現營收人民幣66.67億元，淨利潤人民幣8.27億元，連續三年實現營收、利潤雙增長。再看復星最重要的海外子公司復星葡萄牙保險，2025年收入和淨利潤實現強勁增長，實現歸母淨利潤2.01億歐元，同比增長15.8%，成為復星穩定的利潤來源。復星的全球化生態對復星葡萄牙保險助力甚多，公司業務已從葡萄牙本土覆蓋到歐洲、拉美、非洲等海外區域。2025年葡萄牙保險首次被標普授予A級評級，資產質量與抗風險能力獲國際認可。在國內，復星兩家保險公司也表現不俗。復星保德信人壽全年規模保費達人民幣132.8億元，同比增長41.6%，實現淨利潤人民幣6.5億元，同比大幅增長超492%；復星聯合健康保險2025年的收入達到人民幣78.4億元，同比增長50.1%，全年實現淨利潤人民幣1.39億元，連續五年盈利。核心動力：創新和全球化戰略復星醫藥和復星葡萄牙保險，恰好代表著復星的兩大核心戰略：創新和全球化。復星創業以來，一直將「創新研發」作為核心戰略，香港上市之後開始全球化拓展。經歷了多年的高強度投入和摸索後，創新和全球化戰略成為復星發展的核心動能，帶來持續的「復利」成果。復星醫藥2025年最大的變化，就是創新藥的「爆發」。報告期內，復星醫藥創新藥品收入人民幣98.93億元，同比增長29.59%，佔製藥業務收入比重提升至33.16%；復星醫藥7個創新藥品共16項適應症於境內外獲批上市，6個創新藥品種上市申請獲受理。報告期內，復星還有近40項創新藥臨床試驗獲中、美、歐等監管機構批准，多個核心產品進入關鍵臨床階段，為後續商業化增長奠定堅實管線基礎。最受人關注的還是復宏漢霖的HLX43，作為潛在同類最優的廣譜抗腫瘤PD-L1 ADC，在非小細胞肺癌、婦科腫瘤、食管鱗癌等多個領域展現出「高效、低毒」的顯著優勢。在全球今年1月27日獲准在國內開展臨床試驗，未來有望成為復星的另一個里程碑式的產品。這一年，復星旗下多項創新藥的出海BD令市場印象深刻。比如2026年開年，復星醫藥與衛材株式會社就H藥漢斯狀達成協議，潛在總金額超3億美元。2025年年底，復星醫藥旗下的藥友製藥與輝瑞簽訂全球獨家許可協議，潛在總金額超 20 億美元；復星醫藥產業與生物技術公司Clavis Bio達成戰略合作，可獲得至多72.5億美元付款。全球化方面，復星在全球超過40個國家和地區拓展形成了深度產業佈局，今天已邁向產品、服務、品牌成體系的全球化。2025年復星海外收入達人民幣948.6億元，佔總收入比重同比提升5.4個百分點，達到54.7%。現在復星的全球化不再是 「買全球」，而是 「賺全球」。復星旅文旗下的Club Med，在全球運營67家度假村。報告期內Club Med業績再創歷史新高，錄得營業額人民幣180.7億元，同比增長3.6%；經營利潤達人民幣14.4億元，較2024年增長4.6%。復星旗下的海南礦業，如今已是全球化的「資源+新能源」企業，「出海」成果有聲有色。海礦推進的「海外資源+海南加工」模式，2025年已進入實質運營階段，非洲馬里布谷尼鋰礦全年產出鋰精礦4.5萬噸，首批3萬噸鋰精礦於2026年1月運抵海南洋浦港。此外，海南礦業還通過旗下洛克石油及完成併購的阿曼油田項目，加速打造覆蓋西非、中東、東南亞的「礦產+能源」網絡。國際評級機構展望「穩定」對於市場而言，最關心的還是復星的財務情況。復星國際業績公告顯示，報告期內，現金銀行及定期存款達人民幣611億元；尚未提用的銀行信貸總額合共人民幣1,446億元，總債務佔總資本比率為57%；財務狀況保持健康，現金儲備充裕。國際評級機構普遍確認復星國際的評級展望為「穩定」。在《致股東信》中，郭廣昌表示，目前復星核心產業穩健、流動性充足、銀企關係穩固。公司大股東和管理層已公佈增持計劃，也將推進公司股份回購，加上核心業務持續增長，以及戰略規劃的清晰落地，「我們有信心推動股價回歸合理價值，切實保障股東長期利益。」這次在發佈業績公告的同時，復星也宣佈將致力提升派息率，2026年財政年度目標派息率計劃從目前20%提升到35%。基於公司累計可分派利潤，2026年財政年度的股息預計不低於港幣15億元。有理由預期復星經過這一次的「斷捨離」，為未來復星業務增長更多的確定性。在這次《致股東信》中，郭廣昌也披露了未來中期的財務目標：「力爭推動逐步恢復人民幣百億利潤規模；集團層面目標回籠人民幣600億元資金，將集團層面總負債降至人民幣600億元以下，力爭達成『投資級』評級。」他表示，「復星始終堅守的初心，就是做對的事、做難的事、做需要時間積累的事。未來的復星，我們不去爭一時之快，我們要立長久之基。」 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月31日 - (亞太商訊 via SeaPRwire.com) - 西藏智匯礦業股份有限公司（股票代碼：2546.HK，「智匯礦業」或「本公司」）今日公佈截至2025年12月31日止年度的經審核全年業績。公告顯示，受惠於有色金屬價格上行及產能釋放，公司全年實現營收約人民幣6.16億元，同比增長104.4%；歸母淨利潤達人民幣1.50億元，同比激增168.3%。尤為值得關注的是，公司盈利能力顯著增強，毛利率從去年同期的34.7%進一步優化提升至36.4%。此外，董事會提議派發末期股息每股人民幣0.102元，分紅比例約佔核心利潤的30%，彰顯了公司對股東長期支持的回饋誠意及對未來發展的信心。毛利率顯著優化，高效運營與規模效應釋放盈利彈性2025年，智匯礦業在良好的市場環境下，通過精細化管理實現了成本與收入的良性剪刀差。數據顯示，公司全年銷售成本同比增長99.0%，低於收入增速（104.4%）5.4個百分點，這一結構性優化直接推動了毛利潤以114.4%的幅度增長，毛利率提升至36.4%。這一成績的取得，不僅得益於入選礦石品位的自然提升（鉛+鋅合計6.73%）及規模效應帶來的單位成本攤薄，更源於公司對生產全流程的高效管控。在產量翻倍的背景下，公司依然保持了卓越的成本控制能力，實現了利潤增速遠超營收增速的高質量發展。12號礦床產能釋放，奠定增長基石業績爆發的核心驅動力來自核心資產的全面投產。報告期內，公司12號礦床（Pb12）地下礦山建設項目如期完工，並於2025年6月正式通過安監驗收投入生產。這一里程碑式的進展，不僅為公司提供了新的高品質礦石來源，更極大地延長了礦山的服務年限。疊加露天礦山恢復正常作業，公司鉛、鋅、銅精礦銷量分別實現了160%、76%和311%的大幅增長，為業績翻倍奠定了堅實的產能基礎。堅持高分紅政策，踐行股東回報承諾智匯礦業始終將股東回報視為企業發展的核心責任。隨著2025年12月公司在港交所主板成功上市，資本實力顯著增強的同時，公司亦確立了持續、穩定的分紅政策。基於優異的業績表現，董事會建議派發末期股息每股人民幣0.102元。以此計算，年度分紅金額佔歸母淨利潤比例約30%。這一高分紅舉措充分體現了管理層對現金流生成能力的信心，以及踐行對投資人回報承諾的堅定決心。展望未來智匯礦業管理層表示：「2025年是智匯礦業發展歷程中具有里程碑意義的一年。我們不僅完成了上市願景，更通過技術升級和管理優化，實現了『收入增長快於成本增長』的高質量發展模式。未來，我們將繼續深耕西藏資源優勢，加大勘探投入，並尋求優質的併購機會，致力於成為領先的有色金屬礦業公司，為股東創造長期可持續的價值。」 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月31日 - (亞太商訊 via SeaPRwire.com) - 3月30日，中國領先的豪華新能源車企——賽力斯（股份代號：9927.HK）正式發布2025年度經營業績。報告顯示，2025年，集團收入達約人民幣1648.9億元，同比提升13.63%；歸屬於上市公司股東的淨利潤約人民幣59.6億元，盈利表現穩步向好。 面對新能源汽車行業日趨激烈的市場競爭，公司堅定聚焦豪華新能源賽道，以技術創新為引擎、以產品力為核心，持續深化業務佈局與市場拓展，整體經營業績持續向好，經營質效與品牌價值實現協同提升。產品陣容領跑市場，研發與技術佈局持續領先2025年，賽力斯旗下問界品牌憑藉卓越產品實力與良好用戶口碑，持續引領豪華新能源細分市場。其中，問界M9全年交付超11萬輛，2024年、2025年連續兩年穩坐50萬元級車型銷冠，樹立中國高端新能源旗艦市場全新標杆；問界M8全年交付超15萬輛，上市以來穩居40萬元級別車型銷量榜首，成為中大型豪華新能源市場的核心主力車型；問界M7全年交付超11萬輛，憑藉高性價比與全域智慧化能力持續熱銷，充分展現強大的市場穿透力與用戶認可度。研發層面，2025年賽力斯持續加大核心技術研發投入，報告期內公司研發投入達125.1億元，同比增長77.4%，研發投入強度與增速均位居行業前列。與此同時，公司持續擴充高水準研發團隊，截至2025年底，研發人員規模達到9,019人，累計授權專利提升至8,046件，構建覆蓋整車研發、核心零部件、智慧軟件的全鏈路技術儲備體系，為產品持續迭代與長遠高質量發展築牢堅實技術底座。依託劃時代的領先增程與純電技術平台，賽力斯堅持雙線並行的戰略格局，在2025年新能源汽車市場實現全面豐收，市場認可度與品牌聲譽顯著提升。賽力斯增程業務以37.5%的市占率強勢登頂中國市場第一；與此同時，純電車型銷售占比持續攀升，不僅優化了公司產品結構，更標誌著技術實力與市場競爭力的同步躍升，進一步深植了公司在新能源賽道的全面發展優勢。積極分紅回饋股東，長期成長空間有望进一步打開值得關注的是，賽力斯堅持以穩定分紅回饋廣大股東，與投資者共享高質量發展成果。2025年，公司董事會建議派發截至2025年12月31日止年度末期股息，每股人民幣0.8元（含稅），合計擬派發現金紅利約19億元。該舉措既體現公司對自身長期價值成長的堅定信心，切實保障股東回報，亦彰顯公司穩健的財務狀況與可持續發展能力，持續提升資本市場認可度。從行業發展趨勢來看，當前，新能源汽車正處於技術加速迭代、滲透率持續提升、全球化佈局提速的黃金階段。據EVTank預測，2026年全球新能源汽車銷量有望達到2849.6萬輛，中國市場將達1979.6萬輛；2030年全球銷量有望突破4265.0萬輛，整體滲透率超40%，行業長期增長空間廣闊。賽力斯作為中國豪華新能源汽車領軍企業，以持續高強度研發創新為技術支撐，以差異化產品矩陣與精細化用戶運營為核心驅動，在行業激烈競爭中脫穎而出並實現亮眼業績。未來，公司將繼續深耕豪華新能源賽道，持續推動技術突破與產品升級，加速全球化戰略落地實施，有望進一步打開長期成長空間。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com